Calendar of Events
Diagnostics special report.
Rocky River, DDNews — Epic Sciences has been featured in a special report on liquid biopsy. This report discussed cancer as a heterogeneous disease and reviews sample choice in research and diagnostics.
GenomeWeb: Epic Sciences collaborators share data at AACR on single caner cell analysis, CTC biomarker detection.
New York, GenomeWeb — GenomeWeb reported from the annual meeting of the American Association for Cancer Research (AACR), where several research groups presented studies using Epic Science's no cell left behind™ platform for detecting and analyzing circulating tumor cells (CTCs).
Epic's San Diego lab gains CLIA certification.
Epic Sciences has received its Clinical Laboratory Improvement Amendments (CLIA) license from the Centers for Medicare and Medicaid Services and the State of California for its circulating tumor cell lab in San Diego to advance new cancer diagnostics.